Literature DB >> 19126020

An unusual and serious complication of topical wart treatment with monochloroacetic acid.

Nesrin Tan Baser1, Burcin Yalaz, Ali Cemal Yilmaz, Dogan Tuncali, Gurcan Aslan.   

Abstract

Numerous chemical agents are used in the topical treatment of warts. Monochloroacetic acid (MCAA) is one of these agents, which is used in low or high concentrations in most European countries. MCAA is a strong organic acid which is irritating and corrosive to the skin and has a high systemic toxicity. In addition to wart treatment, it is used for industrial purposes, such as the synthesis of certain organic chemicals. We present a case of joint deformity manifesting after the use of a preparation containing MCAA for topical wart treatment. This underlines the need to reassess the safety of MCAA use for topical wart treatment.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19126020     DOI: 10.1111/j.1365-4632.2008.03789.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  4 in total

1.  Monochloroacetic acid application is an effective alternative to cryotherapy for common and plantar warts in primary care: a randomized controlled trial.

Authors:  Sjoerd C Bruggink; Jacobijn Gussekloo; Paulette F Egberts; Jan Nico Bouwes Bavinck; Margot W M de Waal; Willem J J Assendelft; Just A H Eekhof
Journal:  J Invest Dermatol       Date:  2015-02-05       Impact factor: 8.551

Review 2.  [Physical and chemical emergencies in dermatology].

Authors:  B Malisiewicz; M Meissner; R Kaufmann; E Valesky
Journal:  Hautarzt       Date:  2018-05       Impact factor: 0.751

3.  A full-thickness chemical burn to the hand using formic acid-based anti-wart treatment: a case report and literature review.

Authors:  Olivia Sjökvist; Christian Smolle; David Jensson; Fredrik Huss
Journal:  Scars Burn Heal       Date:  2020-02-05

4.  Third degree formic acid chemical burn in the treatment of a hand wart: a case report and review of the literature.

Authors:  Nicolas Balagué; Philippe Vostrel; Jean-Yves Beaulieu; Jan van Aaken
Journal:  Springerplus       Date:  2014-08-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.